TrialLancet (London, England)2021

Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey.

Mine Durusu Tanriover et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.